Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
en English
en Englishar العربيةbg Българскиzh-CN 简体中文zh-TW 繁體中文hr Hrvatskics Čeština‎da Dansknl Nederlandsfi Suomifr Françaisde Deutschel Ελληνικάhi हिन्दीit Italianoja 日本語ko 한국어no Norsk bokmålpl Polskipt Portuguêsro Românăru Русскийes Españolsv Svenskaca Catalàtl Filipinoiw עִבְרִיתid Bahasa Indonesialv Latviešu valodalt Lietuvių kalbasr Српски језикsk Slovenčinasl Slovenščinauk Українськаvi Tiếng Việtsq Shqipet Eestigl Galegohu Magyarmt Malteseth ไทยtr Türkçefa فارسیaf Afrikaansms Bahasa Melayusw Kiswahiliga Gaeilgecy Cymraegbe Беларуская моваis Íslenskamk Македонски јазикyi יידישhy Հայերենaz Azərbaycan dilieu Euskaraka ქართულიht Kreyol ayisyenur اردوbn বাংলাbs Bosanskiceb Cebuanoeo Esperantogu ગુજરાતીha Harshen Hausahmn Hmongig Igbojw Basa Jawakn ಕನ್ನಡkm ភាសាខ្មែរlo ພາສາລາວla Latinmi Te Reo Māorimr मराठीmn Монголne नेपालीpa ਪੰਜਾਬੀso Afsoomaalita தமிழ்te తెలుగుyo Yorùbázu Zulu
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Back to search
Publication

Preliminary note on the effect of isoniazid and iproniazid in murine leprosy.

GRUNBERG E, TITSWORTH E H. American review of tuberculosis. 1953; 67 (5) : 674-5.
Google Scholar

More information

Type
Journal Article
Author
GRUNBERG E
TITSWORTH E H

Export citations:

  • BibTeX
  • EndNote X3 XML
  • EndNote 7 XML
  • Endnote tagged
  • Marc
  • PubMed XML
  • PubMedId
  • RIS
  • Rtf

More publications on:

Leprosy (Hansen disease)

Share this page:

  • Facebook
  • Email
  • Twitter

Stay up to date with the latest publications and news related to Leprosy.

Subscribe to newsletter

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD